Scientific article
English

Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide

Publication date

2008

Abstract

New prevention strategies for use in developing countries are urgently needed to curb the worldwide HIV/AIDS epidemic. The N-terminally modified chemokine PSC-RANTES is a highly potent entry inhibitor against R5-tropic HIV-1 strains, with an inhibitory mechanism involving long-term intracellular sequestration of the HIV coreceptor, CCR5. PSC-RANTES is fully protective when applied topically in a macaque model of vaginal HIV transmission, but it has 2 potential disadvantages related to further development: the requirement for chemical synthesis adds to production costs, and its strong CCR5 agonist activity might induce local inflammation. It would thus be preferable to find a recombinant analogue that retained the high potency of PSC-RANTES but lacked its agonist activity. Using a strategy based on phage display, we set out to discover PSC-RANTES analogs that contain only natural amino acids. We sought molecules that retain the potency and inhibitory mechanism of PSC-RANTES, while trying to reduce CCR5 signaling to as low a level as possible. We identified 3 analogues, all of which exhibit in vitro potency against HIV-1 comparable to that of PSC-RANTES. The first, 6P4-RANTES, resembles PSC-RANTES in that it is a strong agonist that induces prolonged intracellular sequestration of CCR5. The second, 5P12-RANTES, has no detectable G protein-linked signaling activity and does not bring about receptor sequestration. The third, 5P14-RANTES, induces significant levels of CCR5 internalization without detectable G protein-linked signaling activity. These 3 molecules represent promising candidates for further development as topical HIV prevention strategies.

Keywords

  • Anti-Infective Agents/economics/pharmacology
  • Antiviral Agents/pharmacology
  • Chemokine CCL5/chemistry
  • Chemokines/pharmacology
  • Endocytosis/drug effects
  • HIV/drug effects
  • Hela Cells
  • Humans
  • Leukocytes, Mononuclear/drug effects/virology
  • Protein Engineering
  • Receptors, CCR5/metabolism
  • Receptors, Virus/metabolism
  • Recombinant Proteins/pharmacology
  • Reproducibility of Results
  • Signal Transduction/drug effects

Citation (ISO format)

GAERTNER, Hubert François et al. Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide. In: Proceedings of the National Academy of Sciences of the United States of America, 2008, vol. 105, n° 46, p. 17706–17711. doi: 10.1073/pnas.0805098105

Main files (1)

Article (Accepted version)

Secondary files (3)

Supplemental data - I
Supplemental data - III
Supplemental data - II

Identifiers

Additional URL for this publication

http://www.pnas.org/content/105/46/17706.full

Journal ISSN

0027-8424
632views
2downloads

Technical informations

Creation

31/03/2009 11:34:00

First validation

31/03/2009 11:34:00

Update

08/01/2025 10:35:27

Status update

08/01/2025 10:35:27

Last indexation

08/01/2025 10:36:48
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated